Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T de Witte

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Bone Marrow Transplantation|July 20, 2007
Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusionH Levenga, R Woestenenk, A V Schattenberg, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Bone Marrow Transplantation|September 15, 2015
Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMTT Ruutu, L C de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|December 5, 2012
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMTR Martino, L de Wreede, M Fiocco, et al.
Bone Marrow Transplantation|November 29, 2016
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysisT Ruutu, A Gratwohl, D Niederwieser, et al.
Leukemia|January 17, 2003
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trialS Keating, S Suciu, T de Witte, et al.
Leukemia|July 24, 2012
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblingsN Kröger, T Zabelina, L de Wreede, et al.
Blood|September 1, 1995
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patientsH J Kolb, A Schattenberg, J M Goldman, et al.
Leukemia|December 26, 2001
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantationT de Witte, F Pikkemaat, J Hermans, et al.
Leukemia|March 4, 2005
ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cellsJ Nigten, M C Breems-de Ridder, C A J Erpelinck-Verschueren, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Bone Marrow Transplantation|July 20, 2007
Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusionH Levenga, R Woestenenk, A V Schattenberg, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Bone Marrow Transplantation|September 15, 2015
Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMTT Ruutu, L C de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|December 5, 2012
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMTR Martino, L de Wreede, M Fiocco, et al.
Bone Marrow Transplantation|November 29, 2016
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysisT Ruutu, A Gratwohl, D Niederwieser, et al.
Leukemia|January 17, 2003
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trialS Keating, S Suciu, T de Witte, et al.
Leukemia|July 24, 2012
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblingsN Kröger, T Zabelina, L de Wreede, et al.
Blood|September 1, 1995
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patientsH J Kolb, A Schattenberg, J M Goldman, et al.
Leukemia|December 26, 2001
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantationT de Witte, F Pikkemaat, J Hermans, et al.
Leukemia|March 4, 2005
ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cellsJ Nigten, M C Breems-de Ridder, C A J Erpelinck-Verschueren, et al.
Pageof 22